Cargando…
Long-term effect of venetoclax therapy in a patient with the transformation of chronic lymphocytic leukemia into Richter’s syndrome
Richter’s syndrome (RS) is the next step in the progression of chronic lymphocytic leukemia (CLL) progression. It leads to reduced overall patient survival, the necessity of aggressive chemotherapy and a decline in the quality of life. The first line of RS treatment includes traditional chemotherapy...
Autores principales: | Tutaeva, Victoria Vladimirovna, Ovsannikova, Maria Romanovna, Bobin, Alexander Nikolaevich, Kuchma, Yurii Miroslavovich, Rukavitsin, Oleg Anatolievich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589463/ https://www.ncbi.nlm.nih.gov/pubmed/36299674 http://dx.doi.org/10.1093/omcr/omac111 |
Ejemplares similares
-
Correction to: Long-term effect of venetoclax therapy in a patient with the transformation of chronic lymphocytic leukemia into Richter’s syndrome
Publicado: (2023) -
Tumor Lysis Syndrome Caused by Unrecognized Richter’s Transformation of Chronic Lymphocytic Leukemia: Treatment With Venetoclax for Suspected Disease Progression
por: Chango Azanza, Juan Jose, et al.
Publicado: (2020) -
An Approach to Diagnosis of Richter Transformation in Chronic Lymphocytic Leukemia
por: Broadway-Duren, Jackie
Publicado: (2022) -
Richter's transformation as leptomeningeal infiltration in a chronic lymphocytic leukemia patient receiving venetoclax. Could blood‐brain barrier be a disease “sanctuary” during venetoclax treatment?
por: Dimou, Maria, et al.
Publicado: (2021) -
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia
por: Nadeu, Ferran, et al.
Publicado: (2022)